220 related articles for article (PubMed ID: 16014681)
1. Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
Bohgaki T; Amasaki Y; Nishimura N; Bohgaki M; Yamashita Y; Nishio M; Sawada KI; Jodo S; Atsumi T; Koike T
Ann Rheum Dis; 2005 Aug; 64(8):1165-73. PubMed ID: 16014681
[TBL] [Abstract][Full Text] [Related]
2. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
[TBL] [Abstract][Full Text] [Related]
4. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
5. Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction.
Shimoda Y; Satoh M; Nakamura M; Akatsu T; Hiramori K
Clin Sci (Lond); 2005 Apr; 108(4):339-47. PubMed ID: 15603556
[TBL] [Abstract][Full Text] [Related]
6. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).
Mannucci PM; Vanoli M; Forza I; Canciani MT; Scorza R
Haematologica; 2003 Aug; 88(8):914-8. PubMed ID: 12935979
[TBL] [Abstract][Full Text] [Related]
8. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.
Tan FK; Zhou X; Mayes MD; Gourh P; Guo X; Marcum C; Jin L; Arnett FC
Rheumatology (Oxford); 2006 Jun; 45(6):694-702. PubMed ID: 16418202
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis.
Ohta S; Harigai M; Tanaka M; Kawaguchi Y; Sugiura T; Takagi K; Fukasawa C; Hara M; Kamatani N
J Rheumatol; 2001 Aug; 28(8):1756-63. PubMed ID: 11508576
[TBL] [Abstract][Full Text] [Related]
11. Detection of large macrophage colony forming cells in the peripheral blood of patients with rheumatoid arthritis.
Horie S; Nakada K; Masuyama J; Yoshio T; Minota S; Wakabayashi Y; Hirose S; Kano S
J Rheumatol; 1997 Aug; 24(8):1517-21. PubMed ID: 9263144
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells.
Obeid D; Nguyen J; Lesavre P; Bauvois B
Oncogene; 2007 Jan; 26(1):102-10. PubMed ID: 16799629
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.
Kirino Y; Takeno M; Murakami S; Kobayashi M; Kobayashi H; Miura K; Ideguchi H; Ohno S; Ueda A; Ishigatsubo Y
Arthritis Rheum; 2007 Feb; 56(2):464-75. PubMed ID: 17265482
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
16. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
[TBL] [Abstract][Full Text] [Related]
17. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
[TBL] [Abstract][Full Text] [Related]
19. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis.
Mokuda S; Miyazaki T; Ubara Y; Kanno M; Sugiyama E; Takasugi K; Masumoto J
Arthritis Res Ther; 2015 Sep; 17():275. PubMed ID: 26419626
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB; Sokolowska M; Chodynicka B
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
